The Antiphospholipid Syndrome

  • N. Paul Hudson
Part of the Contemporary Internal Medicine book series (COIM, volume 3)


A 31-year-old white male was first admitted to the Ohio State University Hospital after the sudden onset of expressive aphasia and right arm weakness. He had been healthy until several months prior when he developed scrotal edema followed by anasarca. While hospitalized elsewhere for evaluation he denied any symptoms of gastrointestinal, rheumatic, cardiopulmonary, or systemic illness as well as medications or allergies. Findings included anemia (Hct = 32%), thrombocytopenia (53,000/cm3), renal insufficiency (creat = 2.2; creat clr = 58ml/min), nephrotic syndrome (32 gm protein/24 hr, cholesterol = 408, total protein = 3.5 gm), a normal IVP, and a cerebral CT that was reportedly negative. When focal neurologic deficits, appeared he was transferred.


Systemic Lupus Erythematosus Lupus Anticoagulant Anticardiolipin Antibody Cutaneous Lupus Erythematosus Atrial Myxoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Maddison PJ, Provost TT, Reichlin M: Serological findings in patients with “ANA-negative” systemic lupus erythematosus. Medicine. 1981;60:87–94.PubMedCrossRefGoogle Scholar
  2. 2.
    Alarcon-Segovia D, Sanchez-Guerrero J: Primary antiphospholipid syndrome. J Rheumatol. 1989;16:482488.Google Scholar
  3. 3.
    Hughes GRV, Asherson RR, Khamashta MA: Antiphospholipid syndrome: Linking many specialties. Ann Rheum Dis. 1989;48:355–356.PubMedCrossRefGoogle Scholar
  4. 4.
    Colaco CB, Elkon KB: The lupus anticoagulant. Arthritis Rheuma. 1985;28:67–74.CrossRefGoogle Scholar
  5. 5.
    Meyer O, et al: Antiphospholipid antibodies: A disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE. J Rheumatol. 1987;14:502–506.PubMedGoogle Scholar
  6. 6.
    Asherson RA, et al: Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med. 1989;86:391–396.PubMedCrossRefGoogle Scholar
  7. 7.
    Anderson NE, Ali MR: The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheu Dis 1984;43:760–763.CrossRefGoogle Scholar
  8. 8.
    Asherson RA, et al: Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE. Rheumatol Int 1985;5:91–93.PubMedCrossRefGoogle Scholar
  9. 9.
    Mackworth-Young CG, Loizou S, Walport MJ: Primary antiphospholipid syndrome: Features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis. 1989;48:362–367.PubMedCrossRefGoogle Scholar
  10. 10.
    Weidmann CE, et al: Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol. 1988;15:74–79.PubMedGoogle Scholar
  11. 11.
    Gharavi AE, et al: Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987;46:1–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Mueh JR, Herbst KD, Rapaport SI: Thrombosis in patients with the lupus anticoagulant. Ann Intern Med. 1980;92:156–159.PubMedCrossRefGoogle Scholar
  13. 13.
    Khamashta MA, et al: Immune mediated mechanism for thrombosis: Antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis. 1988;47:849–854.PubMedCrossRefGoogle Scholar
  14. 14.
    Lockshin MD, et al: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 1985;313:152–156.PubMedCrossRefGoogle Scholar
  15. 15.
    Lockshin MD: Editorial: Anticardiolipin antibody. Arthritis Rheum. 1987;30:471–472.PubMedCrossRefGoogle Scholar
  16. 16.
    Hanly JG, et al: Lupus pregnancy: A prospective study of placental changes. Arthritis Rheum. 1988;31:358–366.PubMedCrossRefGoogle Scholar
  17. 17.
    Asherson RA, Zulman J, Hughes GRV: Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies. Ann Rheum Dis. 1989;48:232–235.PubMedCrossRefGoogle Scholar
  18. 18.
    Asherson RA, et al: Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the “lupus anticoagulant” in systemic lupus erythematosus. J Rheumatol. 1989;16:219–224.PubMedGoogle Scholar
  19. 19.
    Steen VD, Ramsey-Goldman R: Phenothiazine-induced systemic lupus erythematosus with superior vena cava syndrome: Case report and review of the literature. Arthritis Rheum. 1988;31:923–926.PubMedCrossRefGoogle Scholar
  20. 20.
    Drew P, et al: Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies. Ann Rheum Dis. 1987;46:612–616.PubMedCrossRefGoogle Scholar
  21. 21.
    Asherson RA, et al: Antiphospholipid antibodies: A risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the ‘primary’ antiphospholipid syndrome. Ann Rheum Dis. 1989;48:358–361.PubMedCrossRefGoogle Scholar
  22. 22.
    Averbuch M, Levo Y: Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant. Ann Rheum Dis. 1986;45:435–437.PubMedCrossRefGoogle Scholar
  23. 23.
    Kincaid-Smith P, Fairley KF, Kloss M: Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. QJ Med. 1988;69:795–814.Google Scholar
  24. 24.
    Asherson RA, et al: Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: Association with antiphospholipid antibodies. Ann Rheum Dis. 1987;46:605–611.PubMedCrossRefGoogle Scholar
  25. 25.
    Maaravi Y, et al: Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus. Ann Rheum Dis. 1989;48:853–855.PubMedCrossRefGoogle Scholar
  26. 26.
    Asherson RA, et al: Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischemie attacks. Ann Rheum Dis. 1988;47:947–953.PubMedCrossRefGoogle Scholar
  27. 27.
    Giansiracusa DF, Stafford-Brady F: A 35-year-old woman with recurrent strokes, an intracardiac lesion, anemia and thrombocytopenia. N Engl J Med. 1988;319:699–712.CrossRefGoogle Scholar
  28. 28.
    Khamashta MA, et al: Chorea in systemic lupus erythematosus: Association with antiphospholipid antibodies. Ann Rheum Dis. 1988;47:681–683.PubMedCrossRefGoogle Scholar
  29. 29.
    Chartash EK, et al: Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med. 1989;86:407–412.PubMedCrossRefGoogle Scholar
  30. 30.
    Ford PM, Ford SE, Lillicrap DP: Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol. 1988;15:597–600.PubMedGoogle Scholar
  31. 31.
    Gur H, et al: Severe congestive lupus cardiomyopathy complicated by an intracavitary thrombus: A clinical and echocardiographic followup. J Rheumatol. 1988;15:1278–1280.PubMedGoogle Scholar
  32. 32.
    Leventhal LJ, et al: Antiphospholipid antibody syndrome with right atrial thrombosis mimicking an atrial myxoma. Am J Med. 1989;87:111–113.PubMedCrossRefGoogle Scholar
  33. 33.
    Howe HS, et al: Pulmonary hemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann Rheum Dis. 1988;47:869–872.PubMedCrossRefGoogle Scholar
  34. 34.
    Deleze MC, Oria C, Alarcon-Segovia D: Occurence of both hemolytic anemia and thrombocytopenic purpura (Evan’s syndrome) in systemic lupus erythematosus: relationship to antiphospholipid antibodies. J Rheumatol. 1988;15:611–615.PubMedGoogle Scholar
  35. 35.
    Agudelo CA, Wise CM, Lyles MF: Pure red cell aplasia in procainamide induced systemic lupus erythematosus: Report and review of the literature. J Rheumatol. 1988;15:1431–1432.PubMedGoogle Scholar
  36. 36.
    Hazeltine M, et al: Antiphospholipid antibodies in systemic lupus erythematosus: Evidence of an association with positive Coombs’ and hypocomplementemia. J Rheumatol. 1988;15:80–86.PubMedGoogle Scholar
  37. 37.
    Englert HJ, et al: Clinical and immunologic features of livido reticularis in lupus: A case-control study. Am J Med. 1989;87:408–410.PubMedCrossRefGoogle Scholar
  38. 38.
    Alarcon-Segovia D, Cardiel MH, Reyes E: Antiphopholipid arterial vasculopathy. J Rheumatol. 1989;16:762–767.PubMedGoogle Scholar
  39. 39.
    Lie JT: Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol. 1989;16:713–715.PubMedGoogle Scholar
  40. 40.
    Alarcon-Segovia D: Pathogenic potential of antiphospholipid antibodies. J Rheumatol. 1988;15:890–893.PubMedGoogle Scholar
  41. 41.
    Asherson RA, et al: Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann Rheum Dis. 1985;44:823–825.PubMedCrossRefGoogle Scholar
  42. 42.
    Koskela P, et al: Significance of false positive syphilis reactions and anticardiolipin antibodies in a nationwide series of pregnant women. J Rheumatol. 1988;15:70–73.PubMedGoogle Scholar
  43. 43.
    Petri M, et al: Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion: A controlled, prospective study of forty-four women. Arthritis Rheum. 1987;30:601–606.PubMedCrossRefGoogle Scholar
  44. 44.
    Asherson RA, Lubbe WF: Cerebral and valve lesions in sle: association with antiphospholipid antibodies. J Rheumatol. 1988;15:539–543.PubMedGoogle Scholar
  45. 45.
    Sturfelt G, et al: Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis and Rheum. 1987;30:382–388.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • N. Paul Hudson

There are no affiliations available

Personalised recommendations